CASP & OPAT Publications

2023

• Marx AH, Nowicki DN, Carlson RB, Schultz KM, Sickbert-Bennett E, Weber DJ. Bacille Calmette-Guérin preparation and intravesical administration to patients with bladder cancer: Risks to healthcare personnel and patients, and mitigation strategies. Infect Control Hosp Epidemiol. 2023 Dec 11:1-6. doi: 10.1017/ice.2023.259. Epub ahead of print. PMID: 38073548.
• Marx A, McCue A, Perhac A. Retrospective Analysis of Vancomycin and Fidaxomicin Use for Clostridium Difficile Infections at University of North Carolina Medical Center. Poster presented at: Annual American Society of Health-System Pharmacists (ASHP) Midyear Conference; 2023 Dec 3-7; Anaheim, CA. [Poster at right]

ID Week 2023 Conference Research Posters

• Marx AH, Mavrogiorgos N, Barzin A. ‘I always feel like, somebody’s watching me’–Multimodal Antimicrobial Stewardship Supports Antibiotic Prescribing for Common Infections within the UNC Health Virtual Practice. Presented at IDWeek 2023, Boston, MA, October 2023.
• Doligalski C, Lachiewicz A, Friedland A, Snider C, Bowen A, Marx AH, Byku M, Bartelt LA. Dalbavancin for challenging left ventricular assist device driveline infections. Accepted for presentation at IDWeek 2023, Boston, MA, October 2023. 
• Fabricio J, Swartwood M, Oosterwyk T, Schranz A, Farel C, Mavrogiorgos N, Bowman M, Kinlaw A, Boerneke R. One Day Holiday: An Approach to Managing Daptomycin-Induced CK Elevations in OPAT. Poster presentation, Infectious Diseases Society of America Annual Meeting (IDWeek), October 2023.
• Hamilton C, Fabricio J, Wilson W, Riley I, Boyd J, Swartwood M, Olm-Shipman C, Willis Z. Improving Diagnostic Stewardship of Respiratory Culture Collection in the Pediatric ICU. Poster presentation, Infectious Diseases Society of America annual meeting (IDWeek), October 2023.
• Kane N, Rikard R, McCrory K, Marx AM. Administration of Crushed Posaconazole Delayed Release Tablets Failed to Achieve Therapeutic Levels. Accepted for presentation at IDWeek 2023, Boston, MA, October 2023. 
• McCrary LM, Shah S, Slain D, Stoner BJ, Marx AH, Schranz AJ. Widespread emergence of infective endocarditis due to Serratia spp.: Results of a large multicenter cohort. Accepted for presentation at IDWeek 2023, Boston, MA, October 2023. 
• Stromberg J, Mavrogiorgos N, Jones T, Marx A. Measuring the Impact of PCR-based MRSA Nares Screening on Vancomycin Use and Duration of Vancomycin Among Pneumonia Patients at an Academic Medical Center. Accepted for presentation at IDWeek 2023, Boston, MA, October 2023. 
• Swartwood M, Schranz A J, Farel C, Mavrogiorgos N, Fabricio J, Bowman M C, Oosterwyk T M, Boerneke R. Early Intervention: Readmission Reduction Efforts in OPAT via Early Patient Contact. Poster presentation, Infectious Diseases Society of America annual meeting (IDWeek), October 2023.
• Ponder M, Boerneke R, Schranz A, Swartwood M, Farel C, Kinlaw A. Heterogeneous OPAT regimens within and across infection diagnoses: Day-level medication use patterns among 2072 OPAT patients. Antimicrob Steward Healthc Epidemiol. 2023 Sep 29;3(Suppl 2):s43–4. doi: 10.1017/ash.2023.278. PMCID: PMC10594195.

Society for Healthcare Epidemiology of America Spring Conference 2023 Posters:

• Rausch E, Vemuri K, Anderman TM, Daniels L, Fabricio J, Lachiewicz A, Marx A, Seña AC, van Duin D, Bartelt LA. Eravacycline Associated Hypofibrinogenemia: A Case Series of Transplant Patients With Mycobacterium Abscessus Infections and Review of Literature. Open Forum Infect Dis. 2022 Dec 15;9(12):ofac591. doi: 10.1093/ofid/ofac591. Erratum in: Open Forum Infect Dis. 2023 Apr 11;10(4):ofad053. PMID: 36570967; PMCID: PMC9772872.
• Doughman D, Marx AH, Mavrogiorgos N. Shorter. Safer. Better. Pledge Campaign to Increase Uptake of Shortest Effective Durations of Antimicrobial Therapy, Open Forum Infect Dis, Volume 9, Issue Supplement_2, December 2022, ofac492.771, https://doi.org/10.1093/ofid/ofac492.771.
• Ciccone EJ, Gutierrez-Ramirez AT, Kabugho L, Kibaba G, Mwebembezi F, Baguma E, Muhindo R, Boyce RM, Mulogo EM. Knowledge and perceptions of antibiotics among village health workers in southwestern Uganda. American Society of Tropical Medicine and Hygiene Annual Conference; 2022 October 31; Seattle, WA
• Mackow NA, Eiffert SR, Kinlaw AC, Kooken BW, Miller MB, Bartelt LA, Ciccone EJ. Clinical management changes after positive multiplex gastrointestinal pathogen panel testing for evaluation of diarrhea. IDWeek; 2022 October 22; Washington, DC, USA
• Ciccone EJ, Willis ZI. ED respiratory viral testing and antibiotic prescribing behavior. J Pediatr. 2022 Dec;251:220-224. doi: 10.1016/j.jpeds.2022.08.057. PMID: 36464405.

• Wang ME, Felder K, Newland JG, Hersh AL, Rajapakse NS, Willis ZI, Banerjee R, Gerber JS, Schwenk HT, Vaz LE. Pediatric antimicrobial stewardship practices at discharge: A national survey. Infect Control Hosp Epidemiol. 2022 Nov;43(11):1686-1688. doi: 10.1017/ice.2021.283. Epub 2021 Jul 16. PMID: 34269167.
• Seidelman JL, Moehring RW, Weber DJ, Anderson DJ, Lewis SS. The impact of patient-reported penicillin or cephalosporin allergy on surgical site infections. Infect Control Hosp Epidemiol. 2022 Jul;43(7):829-833. doi: 10.1017/ice.2021.232. Epub 2021 Jun 9. PMID: 34105449.\
• Hamilton C, Stancill L, Wilson W, Thomas M, Olm-Shipman C, Boyd J, Willis ZI. Diagnostic Stewardship of Respiratory Cultures in the Pediatric ICU: A Quality Improvement Approach. Poster presentation, 12^th Annual International Pediatric Antimicrobial Stewardship Conference, St. Louis, MO, June 2022.
• Rausch E and Wilson W. Efficacy of Non–Carbapenem Antibiotics for the Treatment of Ceftriaxone–Resistant Enterobacterales. Poster presentation, 25th Annual Making a Difference in Infectious Diseases Conference, Orlando, FL, May 2022.
• Sathitakorn O, Jantarathaneewat K, Weber DJ, Warren DK, Nanthapisal S, Rutjanawech S, Apisarnthanarak P, Apisarnthanarak A. The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study. Am J Infect Control. 2022 May;50(5):581-584. doi: 10.1016/j.ajic.2022.01.030.
• Ponder M, Kinlaw A, Daniels L, Norris A, Alby K. April 2022, SHEA Spring conference: Susceptibility reporting and antibiotic prescribing for UTIs in the inpatient setting: A nudge toward stewardship. Poster presentation, Society for Healthcare Epidemiology of America Spring Conference, April 2022.
• Spicer JO, Armstrong WS, Schwartz BS, et al.: The IDSA Antimicrobial Stewardship Curriculum Workgroup. Evaluation of the Infectious Diseases Society of America’s Core Antimicrobial Stewardship Curriculum for Infectious Diseases Fellows. Clinical Infectious Diseases. 2022 Mar 23;(ciab600). doi:10.1093/cid/ciab600

• Apisarnthanarak A, Weber DJ. Strategy to limit multidrug-resistant Acinetobacter baumannii transmission in a cohort coronavirus disease 2019 (COVID-19) critical care unit. Infect Control Hosp Epidemiol. 2021 Jun 24:1-2. doi: http://10.1017/ice.2021.289
• Willis ZI, de St Maurice A. A Piece of the Puzzle: The Role of Molecular Testing in Antimicrobial Stewardship. J Pediatric Infect Dis Soc. 2021 Jun 15:piab037. doi: 10.1093/jpids/piab037.
• Seidelman JL, Moehring RW, Weber DJ, Anderson DJ, Lewis SS. The impact of patient-reported penicillin or cephalosporin allergy on surgical site infections. Infect Control Hosp Epidemiol. 2021 Jun 9:1-5. doi: https://doi.org/10.1017/ice.2021.232
• Ross RK, Gerber JS, Willis ZI, Hersh AL, Kinlaw AC. Outpatient Fluoroquinolone Use in Children, 2000-2018. J Pediatric Infect Dis Soc. 2021 May 28;10(5):576-585. doi: 10.1093/jpids/piaa156.
• Jantarathaneewat K, Apisarnthanarak A, Limvorapitak W, Weber DJ, Montakantikul P. Pharmacist-Driven Antibiotic Stewardship Program in Febrile Neutropenic Patients: A Single Site Prospective Study in Thailand. Antibiotics (Basel). 2021 Apr 17;10(4):456. doi: http://10.3390/antibiotics10040456
• Luther VP, Shnekendorf R, Logan A, et al.: The IDSA Antimicrobial Stewardship Curriculum Workgroup. Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders through Curriculum Development and Dissemination. Clinical Infectious Diseases. 2021;(ciab244). doi:10.1093/cid/ciab244
• Garner L, Ngo Susan, Kaplan JB, Wilson WS, and McKinzie CJ. Evaluation of posaconazole dosing in children and young adults: a single-center review. J Pediatr Pharmacol Ther. 2021;26(8):834-840. doi: 10.5863/1551-6776-26.8.834
• Garcia Reeves AB, Trogdon JG, Stearns SC, Lewis JW, Weber DJ, Weinberger M. Are Rates of Methicillin-Resistant Staphylococcus aureus and Clostridioides difficile Associated With Quality and Clinical Outcomes in US Acute Care Hospitals? Am J Med Qual. 2021 Mar-Apr 01;36(2):90-98. doi: http://10.1177/1062860620942310
• Garcia Reeves AB, Stearns SC, Trogdon JG, Lewis JW, Weber DJ, Weinberger M. Impact of California’s mandate for antimicrobial stewardship programs on rates of methicillin-resistant Staphylococcus aureus and Clostridioides difficile infection in acute-care hospitals. Infect Control Hosp Epidemiol. 2021 Mar;42(3):298-304. doi: http://10.1017/ice.2020.446
• Daniels LM, Weber DJ. Interventions to improve antibiotic prescribing at hospital discharge: A systematic review. Infect Control Hosp Epidemiol. 2021 Jan;42(1):96-99.

2020

• OPAT Delivery during COVID-19. Michael J Swartwood, BSN, RN, CAPM, Renae A Boerneke, PharmD, BCPS, Alan C Kinlaw, PhD, Nikolaos Mavrogiorgos, MD, Ashley Marx, PharmD, Emily J Ciccone, MD, MHS, Asher J Schranz, MD, Mary C Bowman, MD, PhD, Claire E Farel, MD, MPH. Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S308, https://doi.org/10.1093/ofid/ofaa439.676 Published: 31 December 2020
• Identifying Intervention Opportunities to Prevent Readmissions during OPAT. Michael J Swartwood, BSN, RN, CAPM, Claire E Farel, MD, MPH, Nikolaos Mavrogiorgos, MD, Renae A Boerneke, PharmD, BCPS, Ashley Marx, PharmD, Emily J Ciccone, MD, MHS, Asher J Schranz, MD, Alan C Kinlaw, PhD. Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S365, https://doi.org/10.1093/ofid/ofaa439.801 Published: 31 December 2020
• Post-discharge Care Coordination Telephone Call for Patients Enrolled in the UNC OPAT Program. Renae A Boerneke, PharmD, BCPS, Michael J Swartwood, BSN, RN, CAPM, Alan C Kinlaw, PhD, Anita Holt, RN, Nikolaos Mavrogiorgos, MD, Ashley Marx, PharmD, Emily J Ciccone, MD, MHS, Asher J Schranz, MD, Mary C Bowman, MD, PhD, Claire E Farel, MD, MPH. Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S370, https://doi.org/10.1093/ofid/ofaa439.812 Published: 31 December 2020
• Mackenzie Warner, Sydney Browder, Michael Swartwood, Nikolaos Mavrogiorgos, Howard Kashefsky, Ashley Marx. (2020). Patients Treated for Lower Extremity Osteomyelitis in an Outpatient Parenteral Antibiotic Therapy (OPAT) Program.
• Kinlaw AC, Marx AH, Farel CE. Bias-Corrected Estimates of Time-Varying Adverse Drug Event Rates for Patients on Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis. 2018 Jul 2;67(2):316-318. doi: 10.1093/cid/ciy104.
• Cawcutt KA, Patel R, Gerber J, Caliendo AM, Cosgrove SE, Ashley ED, Garzaro P, Miller M, Lautenbach E; IDSA Research Summit ‘Leveraging Existing and Novel Diagnostics for Optimizing Outpatient Antibiotic Stewardship in Patients with Respiratory Tract Infections’ Group. Leveraging Existing and Soon-to-Be-Available Novel Diagnostics for Optimizing Outpatient Antibiotic Stewardship in Patients with Respiratory Tract Infections. Clin Infect Dis. 2020 Dec 4:ciaa1815. doi: 10.1093/cid/ciaa1815. Epub ahead of print.
• Parr JB.Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia. JAMA Intern Med. Published online October 20, 2020. doi:10.1001/jamainternmed.2020.6557
• Willis ZI, Wilson WS. Revised Daptomycin Interpretation Criteria for Enterococcus faecium: What Are the Implications for Children? J Pediatric Infect Dis Soc. 2020;9(2):265-267. doi:10.1093/jpids/piz066
• Daniels LM, Weber DJ. Interventions to improve antibiotic prescribing at hospital discharge: A systematic review. Infection Control and Hospital Epidemiology 2020 Sept 1: 1-4 doi: 10.1017/ice.2020.367
• Layton JB, McGrath LJ, Sahrmann JM, Ma Y, Dharnidharka VR, O’Neil C, Weber DJ, Butler AM. Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease. Vaccine. 2020 Jul 14;38(33):5178-5186.
• Rhea S, Jones K, Endres-Dighe S, Munoz B, Weber DJ, Hilscher R, MacFarquhar J, Sickbert-Bennett E, DiBiase L, Marx A, Rineer J, Lewis J, Bobashev G. Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network. PLoS One. 2020;15(6):e0234031. Published 2020 Jun 11. doi:10.1371/journal.pone.0234031
• Rimland CA, Morgan CE, Bell GJ, Kim MK, Hedrick T, Marx A, Bramson B, Swygard H, Napravnik S, Schmitz JL, Carson SS, Fischer WA, Eron JJ, Gay CL, Parr JB. Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center. MedRxiv 2020.05.13.20100404; doi: https://doi.org/10.1101/2020.05.13.20100404.

2019

• Asher Schranz, Alan Kinlaw, Michael Swartwood, Ashley Marx, Renae Boerneke, Tenesha Medlin, Erin Mays, Claire E. Farel. OPAT at the End of Life?: Short and Long-Term Mortality Following Outpatient Parenteral Antibiotic Therapy. Open Forum Infectious Diseases, Volume 6, Issue supplement 2, 23 October 2019, Page S383, https://doi.org/10.1093/ofid/ofz360.944
• Bobbi Jo Walston, Lisa Fletcher, William Wilson, Renae Boerneke, Ashley Marx, John Vargas, Claire Farel. Implementation of a Pharmacist-led Intervention for Infectious Diseases Patients Discharged on Antimicrobials: the Infectious Diseases Discharge Outreach and Retention (ID DOOR) Program. Open Forum Infectious Diseases, Volume 6, Issue supplement 2, 23 October 2019, Pages S333–S334, https://doi.org/10.1093/ofid/ofz360.815
• Walker Mason, Alan Kinlaw, Emily Ciccone, Kevin Alby, Melissa Miller, Lindsay Daniels. Implementation of rapid diagnostic testing and antimicrobial stewardship interventions to reduce time to optimal therapy for Staphylococcus aureus bacteremia. October 2019 (Poster requires UNC Health log in.) Summary: This was a successful multidisciplinary collaborative project implementing rapid diagnostic testing and antimicrobial stewardship interventions to reduce time to optimal antimicrobial therapy for patients with for S. aureus bacteremia.
• Zach Willis, May-Britt Sten, Ronald Davis, Donna Krzastek, Lindsay Daniels, Jon Juliano, Clare Mock, Michael Swartwood, and Will Stanley. Implementation of Antibiotic Time Outs at UNC Medical Center. October 2019.
• Emily Ciccone, Alan C. Kinlaw, Wilbur Woodhouse, Vahini Chundi, Melissa B. Miller, David J. Weber, Jonathan J. Juliano, Ravi Jhaveri, and Zachary Willis on behalf of the UNC Medical Center Carolina Antimicrobial Stewardship Program. Respiratory Viral Testing and Antimicrobial De-escalation Among Hospitalized Patients at a Tertiary Care Facility, 2015-2016: A Matched Cohort Study Series.  Open Forum Infectious Diseases, Volume 6, Issue supplement 2, 23 October 2019, Page S986, https://doi.org/10.1093/ofid/ofz360.2467
• Ashley Marx, Vahini Chundi, Jill Zaccardelli, Jon Oriet, Tim Angle, Michael Swartwood, Lindsay Daniels, Ross Boyce, Jonathan Juliano. Effects of An Antimicrobial Stewardship Team-led Staphylococcus aureus Bacteremia Management Bundle: A Quasi-Experimental Study. Open Forum Infectious Diseases, Volume 6, Issue supplement 2, 23 October 2019, Page S366, https://doi.org/10.1093/ofid/ofz360.904
• Erin Mays, Alan Kinlaw, Michael Swartwood, Asher Schranz, Renae Boerneke, Claire Farel, Ashley Marx. Evaluation of Adverse Drug Reactions due to Common Beta-Lactam Therapies Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program. Open Forum Infectious Diseases, Volume 6, Issue supplement 2, 23 October 2019, Page S332, https://doi.org/10.1093/ofid/ofz360.811
• Asajah Duncan, Alan Kinlaw, Vahini Chundi, Claire Farel, Ashley Marx on behalf of the UNC Medical Center OPAT Program. Vancomycin Treatment and Time to Adverse Drug Reactions During Outpatient Parenteral Antimicrobial Therapy (OPAT). Open Forum Infectious Diseases, Volume 5, Issue suppl_1, 26 November 2018, Pages S554.
• Emily Ciccone, Alan Kinlaw, Vahini Chundi, Melissa Miller, David Weber, Jonathan Juliano, Ravi Jhaveri, Zachary Willis, on behalf of The UNC Antimicrobial Stewardship Team. The Impact of a Positive Respiratory Viral Panel Among Hospitalized Adult Patients with Negative Rapid Influenza Testing at an Academic Tertiary Care Facility: A-matched Cohort Study. Open Forum Infectious Diseases, Volume 5, Issue suppl 1, 26 November 2018, Pages S268.

2018

• Daniels LM, Kufel WD. Clinical review of Clostridium difficile infection: an update on treatment and prevention. Expert Opin Pharmacother. 2018 Nov;19(16):1759-1769. doi: 10.1080/14656566.2018.1524872. Epub 2018 Sep 25. Review. PubMed PMID: 30220230.
• Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm. 2012 Nov 1;69(21):1910-4. doi: 10.2146/ajhp110604.
• Kufel WD, Jeffres MN, MacDougall C, Cho JC, Marx AH, Williams DM. Antimicrobial stewardship education in US colleges and schools of pharmacy. J Antimicrob Chemother. 2018;73(8):2252-2258. doi:10.1093/jac/dky166
• Schultz K, Sickbert-Bennett E, Marx A, Weber DJ, DiBiase LM, Campbell-Bright S, Bode LE, Baker M, Belhorn T, Buchanan M, Goldbach S, Harden J, Hoke E, Huenniger B, Juliano JJ, Langston M, Ritchie H, Rutala WA, Smith J, Summerlin-Long S, Teal L, Gilligan P. Preventable patient harm: A multidisciplinary, bundled approach to reducing Clostridium difficile infections while using a GDH/toxin immunochromagraphic assay/NAAT diagnostic algorithm. J Clin Microbiol. 2018 Jul 11. pii: JCM.00625-18. doi: 10.1128/JCM.00625-18.
• Combating Carbapenem-Resistant Enterobacteriaceae: a presentation by Laurence Wright, PharmD, as a part of the Carolina Antimicrobial Stewardship Program Learning Series, September 2018

2017

• Onyeka Nwankwo, Anh Eichholz, Vahini Chundi, Alan Kinlaw, Tenesha Medlin, Lisa Fletcher, Wesley Kufel, Claire Farel, Ashley Marx. Characterization of Readmissions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program Over a 2-Year Period at UNC Medical Center. Open Forum Infectious Diseases, Volume 4, Issue suppl 1, 1 October 2017, Pages S335, https://doi.org/10.1093/ofid/ofx163.795
• Vahini Chundi, Anh Eichholz, Onyeka Nwankwo, Alan Kinlaw, Wesley Kufel, Tenesha Medlin, Lisa Fletcher, Ashley Marx, Claire Farel. Adverse Drug Reactions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program 2015–2016 at UNC Medical Center. Open Forum Infectious Diseases, Volume 4, Issue suppl 1, 1 October 2017, Pages S341, https://doi.org/10.1093/ofid/ofx163.813
• Emily Ciccone, Vahini Chundi, Melissa Miller, Lauren DiBiase, David Weber, Jonathan Juliano, Ravi Jhaveri,  Zachary Willis, on behalf of the UNC Antimicrobial Stewardship Team. The Impact of Respiratory Viral Testing in Hospitalized Adult Patients at a Tertiary Care Facility. Open Forum Infectious Diseases, Volume 4, Issue suppl 1, 1 October 2017, Pages S510, https://doi.org/10.1093/ofid/ofx163.1323
• Marx A, Daniels L, Miller MB, Weber DJ. Vancomycin Minimum Inhibitory Concentration Is Not a Substitute for Clinical Judgment: Response to Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017 Oct 15;65(8):1428-1429. doi: 10.1093/cid/cix552.
• Kufel WD, Devanathan AS, Marx AH, Weber DJ, Daniels LM. Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection. Pharmacotherapy. 2017 Oct;37(10):1298-1308. doi: 10.1002/phar.1990. Epub 2017 Sep 12. Review. PubMed PMID: 28730660.

Earlier

• Daniels LM, Juliano J, Marx A, Weber DJ. Inhaled Antibiotics for Hospital-Acquired and Ventilator-Associated Pneumonia. Clin Infect Dis. 2017 Feb 1;64(3):386-387. doi: 10.1093/cid/ciw726. Epub 2016 Nov 1
• Roshdy DG, Tran A, LeCroy N, Zeng D, Ou FS, Daniels LM, Weber DJ, Alby K, Miller MB. Impact of a rapid microarray-based assay for identification of positive blood cultures for treatment optimization for patients with streptococcal and enterococcal bacteremia. J Clin Microbiol. 2015 Apr;53(4):1411-4. doi: 10.1128/JCM.00104-15. Epub 2015 Feb 11. PubMed PMID: 25673785; PubMed Central PMCID: PMC4365208.
• Alby K, Daniels LM, Weber DJ, Miller MB. Development of a treatment algorithm for streptococci and enterococci from positive blood cultures identified with the Verigene Gram-positive blood culture assay. J Clin Microbiol. 2013 Nov;51(11):3869-71. doi: 10.1128/JCM.01587-13. Epub 2013 Aug 28.